Sacklers Would Give Up Ownership of Purdue Pharma Under Settlement Proposal

The company is in discussions to resolve thousands of lawsuits. Participants in the talks value the plan at between $10 billion and $12 billion.

Leave a Reply

Your email address will not be published. Required fields are marked *